Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation01:24

One-Compartment Open Model: Wagner-Nelson and Loo Riegelman Method for ka Estimation

531
This lesson introduces two critical methods in pharmacokinetics, the Wagner-Nelson and Loo-Riegelman methods, used for estimating the absorption rate constant (ka) for drugs administered via non-intravenous routes. The Wagner-Nelson method relates ka to the plasma concentration derived from the slope of a semilog percent unabsorbed time plot. However, it is limited to drugs with one-compartment kinetics and can be impacted by factors like gastrointestinal motility or enzymatic degradation.
On...
531
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

70
Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
70
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

74
Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
74
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

107
Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
107
Multi-input and Multi-variable systems01:22

Multi-input and Multi-variable systems

110
Cruise control systems in cars are designed as multi-input systems to maintain a driver's desired speed while compensating for external disturbances such as changes in terrain. The block diagram for a cruise control system typically includes two main inputs: the desired speed set by the driver and any external disturbances, such as the incline of the road. By adjusting the engine throttle, the system maintains the vehicle's speed as close to the desired value as possible.
In the absence...
110
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

141
Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
141

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dual-engineered extracellular vesicles enabling endothelial targeting and EphrinB2 delivery for pulp revascularization.

Journal of nanobiotechnology·2026
Same author

Porcine Deltacoronavirus M Protein Binds NLRP3 to Promote Inflammasome Assembly via Competition with TRIM31.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2026
Same author

ResSAT: enhancing spatial transcriptomics prediction from H&E-stained histology images with an interactive spot transformer.

Genome biology·2026
Same author

Characteristics of pulmonary perfusion and ventilation in healthy adults: a prospective observational study with phase-resolved functional lung magnetic resonance imaging.

BMC medical imaging·2026
Same author

Pseudo-obstruction on single-phase CTPA: unilateral pulmonary vein atresia as the cause of 50 years of hemoptysis.

BMC pulmonary medicine·2026
Same author

Enhanced functional mitochondrial donation through glucose-responsive antioxidant microcarrier-engineered native-like MSCs accelerates diabetic wound healing.

Materials today. Bio·2026

Related Experiment Video

Updated: Jul 12, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K

Multi-View Variational Autoencoder for Missing Value Imputation in Untargeted Metabolomics.

Chen Zhao1, Kuan-Jui Su2, Chong Wu3

  • 1Department of Applied Computing, Michigan Technological University, 1400 Townsend Dr, Houghton, MI, 4993.

Arxiv
|October 24, 2023
PubMed
Summary
This summary is machine-generated.

Whole-genome sequencing (WGS) data improves metabolomics imputation by using a novel multi-view variational autoencoder. This approach enhances data accuracy for better insights into metabolic pathways and disease associations.

Keywords:
Metabolomicsimputationmulti-viewvariational autoencoderwhole genome sequencing

More Related Videos

Untargeted Liquid Chromatography-Mass Spectrometry-Based Metabolomics Analysis of Wheat Grain
07:10

Untargeted Liquid Chromatography-Mass Spectrometry-Based Metabolomics Analysis of Wheat Grain

Published on: March 13, 2020

9.8K
A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

21.0K

Related Experiment Videos

Last Updated: Jul 12, 2025

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches
09:47

Author Spotlight: Advancing Alzheimer's Research – Exploring Early Detection and Multi-Omics Approaches

Published on: December 15, 2023

1.1K
Untargeted Liquid Chromatography-Mass Spectrometry-Based Metabolomics Analysis of Wheat Grain
07:10

Untargeted Liquid Chromatography-Mass Spectrometry-Based Metabolomics Analysis of Wheat Grain

Published on: March 13, 2020

9.8K
A Strategy for Sensitive, Large Scale Quantitative Metabolomics
14:18

A Strategy for Sensitive, Large Scale Quantitative Metabolomics

Published on: May 27, 2014

21.0K

Area of Science:

  • Genomics
  • Metabolomics
  • Bioinformatics

Background:

  • Missing data is a significant challenge in mass spectrometry-based metabolomics, potentially causing biased and incomplete analyses.
  • Integrating whole-genome sequencing (WGS) with metabolomics data offers a promising strategy to improve data imputation accuracy.

Approach:

  • A novel method uses WGS data and reference metabolites for imputing unknown metabolites.
  • A multi-view variational autoencoder models burden scores, polygenic risk scores (PGS), and linkage disequilibrium (LD) pruned single nucleotide polymorphisms (SNPs).
  • This approach extracts features and imputes missing metabolomics data by learning latent representations from both omics datasets.

Key Points:

  • The method effectively imputes missing metabolomics values using genomic information.
  • Evaluated on empirical datasets, the approach outperforms conventional imputation techniques.
  • Achieved -scores > 0.01 for 71.55% of metabolites using 35 template metabolites, PGS, and LD-pruned SNPs.

Conclusions:

  • Integrating WGS data enhances metabolomics imputation, improving data completeness and downstream analyses.
  • This facilitates more comprehensive investigations of metabolic pathways and disease associations.
  • Highlights the value of WGS for metabolomics imputation and multi-modal data integration in precision medicine.